Evidence map›Paper›PMID 42192029›Full record

ArticleEMBO reports2026

CIP2A recruits SLX4-MUS81-XPF in mitosis and protects against replication stress.

Alice Meroni, Annica Pellizzari, Nathalie Varisco, Francesco Leone, Giada Greco, Andrea Hänel, Pascale Brasier-Lutz, Isabell Witzel, Alessandro A Sartori, Manuel Stucki

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alice MeroniDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland. alice.meroni@uzh.ch.ORCID 0000-0003-3568-8207
Annica PellizzariDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.
Nathalie VariscoDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.ORCID 0009-0008-6751-2170
Francesco LeoneDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.ORCID 0009-0001-9296-0097
Giada GrecoDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.
Andrea HänelDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.
Pascale Brasier-LutzDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.
Isabell WitzelDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland.
Alessandro A SartoriInstitute of Molecular Cancer Research, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-2770-0333
Manuel StuckiDepartment of Gynecology, University of Zurich and University Hospital of Zurich, Schlieren, Switzerland. manuel.stucki@uzh.ch.ORCID 0000-0002-9974-0134

Funding

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 310030_219462Swiss Cancer Research Foundation (Swiss Cancer Research) KFS-6185-08-2024
6 · The paper itself

Abstract

DNA replication stress can generate mitotic defects because incompletely replicated chromosomes or unresolved replication intermediates tether sister chromatids and hinder their segregation. We and others recently uncovered a mitotic role for the oncoprotein CIP2A, which promotes chromosome stability and is essential in homologous recombination-deficient (HRD) cells. However, how CIP2A safeguards mitotic genome integrity remains unclear. Here, we investigate the role of CIP2A in mitotic responses to replication stress. We show that replication stress induces a strong increase in CIP2A foci during mitosis, highlighting its involvement in processing under-replicated DNA. In wild-type cells, CIP2A is required for efficient recruitment of the scaffold SLX4 and the nucleases MUS81 and XPF to sites of under-replicated DNA. CIP2A loss disrupts this recruitment and leads to increased anaphase lagging chromosomes and micronuclei formation. CIP2A also contributes to mitotic DNA synthesis (MiDAS), although this varies across cell lines, indicating that MiDAS and SMX complex recruitment are not strictly coupled. Together, our findings identify CIP2A as a regulator of mitotic processing of under-replicated DNA and provide a framework for understanding context-dependent vulnerabilities in cancer cells.

Indexed as

AutoantigensDNA-Binding ProteinsDNA ReplicationEndonucleasesMembrane ProteinsMitosisRecombinasesHeLa CellsHumansIntracellular Signaling Peptides and ProteinsProtein BindingAutoantigensCIP2A protein, humanDNA-Binding ProteinsEndonucleasesIntracellular Signaling Peptides and ProteinsMembrane ProteinsMUS81 protein, humanRecombinasesSLX4 protein, human

Identifiers

PMID42192029
PMCPMC13354792

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.